{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T21:37:10Z","timestamp":1769204230971,"version":"3.49.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s11427-014-4691-5","type":"journal-article","created":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T14:48:42Z","timestamp":1407422922000},"page":"809-817","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mineralocorticoid receptor: a critical player in vascular remodeling"],"prefix":"10.1007","volume":"57","author":[{"given":"ShengZhong","family":"Duan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,8]]},"reference":[{"key":"4691_CR1","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJM199405193302008","volume":"330","author":"GH Gibbons","year":"1994","unstructured":"Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med, 1994, 330: 1431\u20131438","journal-title":"N Engl J Med"},{"key":"4691_CR2","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1056\/NEJM198705283162204","volume":"316","author":"S Glagov","year":"1987","unstructured":"Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med, 1987, 316: 1371\u20131375","journal-title":"N Engl J Med"},{"key":"4691_CR3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1152\/physiol.00020.2006","volume":"21","author":"EA Jones","year":"2006","unstructured":"Jones EA, le Noble F, Eichmann A. What determines blood vessel structure? Genetic prespecification vs. hemodynamics. Physiology, 2006, 21: 388\u2013395","journal-title":"Physiology"},{"key":"4691_CR4","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2011.08.039","volume":"146","author":"M Potente","year":"2011","unstructured":"Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell, 2011, 146: 873\u2013887","journal-title":"Cell"},{"key":"4691_CR5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-physiol-030212-183802","volume":"75","author":"KR Stenmark","year":"2013","unstructured":"Stenmark KR, Yeager ME, El Kasmi KC, Nozik-Grayck E, Gerasimovskaya EV, Li M, Riddle SR, Frid MG. The adventitia: essential regulator of vascular wall structure and function. Annu Rev Physiol, 2013, 75: 23\u201347","journal-title":"Annu Rev Physiol"},{"key":"4691_CR6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/2045-8932.94817","volume":"2","author":"KR Stenmark","year":"2012","unstructured":"Stenmark KR, Frid MG, Yeager M, Li M, Riddle S, McKinsey T, El Kasmi KC. Targeting the adventitial microenvironment in pulmonary hypertension: a potential approach to therapy that considers epigenetic change. Pulmon circulat, 2012, 2: 3\u201314","journal-title":"Pulmon circulat"},{"key":"4691_CR7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1161\/CIRCRESAHA.107.164384","volume":"102","author":"SZ Duan","year":"2008","unstructured":"Duan SZ, Usher MG, Mortensen RM. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature. Circ Res, 2008, 102: 283\u2013294","journal-title":"Circ Res"},{"key":"4691_CR8","doi-asserted-by":"crossref","first-page":"10340","DOI":"10.1073\/pnas.0604260103","volume":"103","author":"FK Swirski","year":"2006","unstructured":"Swirski FK, Pittet MJ, Kircher MF, Aikawa E, Jaffer FA, Libby P, Weissleder R. Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc Natl Acad Sci USA, 2006, 103: 10340\u201310345","journal-title":"Proc Natl Acad Sci USA"},{"key":"4691_CR9","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/nm.3258","volume":"19","author":"CS Robbins","year":"2013","unstructured":"Robbins CS, Hilgendorf I, Weber GF, Theurl I, Iwamoto Y, Figueiredo JL, Gorbatov R, Sukhova GK, Gerhardt LM, Smyth D, Zavitz CC, Shikatani EA, Parsons M, van Rooijen N, Lin HY, Husain M, Libby P, Nahrendorf M, Weissleder R, Swirski FK. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med, 2013, 19: 1166\u20131172","journal-title":"Nat Med"},{"key":"4691_CR10","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","volume":"17","author":"C Weber","year":"2011","unstructured":"Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med, 2011, 17: 1410\u20131422","journal-title":"Nat Med"},{"key":"4691_CR11","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1161\/hh2401.100844","volume":"89","author":"S Sartore","year":"2001","unstructured":"Sartore S, Chiavegato A, Faggin E, Franch R, Puato M, Ausoni S, Pauletto P. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant. Circ Res, 2001, 89: 1111\u20131121","journal-title":"Circ Res"},{"key":"4691_CR12","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1172\/JCI41080","volume":"120","author":"MG Usher","year":"2010","unstructured":"Usher MG, Duan SZ, Ivaschenko CY, Frieler RA, Berger S, Schutz G, Lumeng CN, Mortensen RM. Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. J Clin Invest, 2010, 120: 3350\u20133364","journal-title":"J Clin Invest"},{"key":"4691_CR13","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1006\/jmcc.2000.1238","volume":"32","author":"M Sata","year":"2000","unstructured":"Sata M, Maejima Y, Adachi F, Fukino K, Saiura A, Sugiura S, Aoyagi T, Imai Y, Kurihara H, Kimura K, Omata M, Makuuchi M, Hirata Y, Nagai R. A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol, 2000, 32: 2097\u20132104","journal-title":"J Mol Cell Cardiol"},{"key":"4691_CR14","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.HYP.0000203772.78696.67","volume":"47","author":"K Nagata","year":"2006","unstructured":"Nagata K, Obata K, Xu J, Ichihara S, Noda A, Kimata H, Kato T, Izawa H, Murohara T, Yokota M. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats. Hypertension, 2006, 47: 656\u2013664","journal-title":"Hypertension"},{"key":"4691_CR15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cell.2014.03.012","volume":"157","author":"RM Evans","year":"2014","unstructured":"Evans RM, Mangelsdorf DJ. Nuclear Receptors, RXR, and the Big Bang. Cell, 2014, 157: 255\u2013266","journal-title":"Cell"},{"key":"4691_CR16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrcardio.2010.123","volume":"7","author":"G Lastra","year":"2010","unstructured":"Lastra G, Dhuper S, Johnson MS, Sowers JR. Salt, aldosterone, and insulin resistance: impact on the cardiovascular system. Nat Rev Cardiol, 2010, 7: 577\u2013584","journal-title":"Nat Rev Cardiol"},{"key":"4691_CR17","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med, 2003, 348: 1309\u20131321","journal-title":"N Engl J Med"},{"key":"4691_CR18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med, 1999, 341: 709\u2013717","journal-title":"N Engl J Med"},{"key":"4691_CR19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"F Zannad","year":"2011","unstructured":"Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B, Group E-HS. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med, 2011, 364: 11\u201321","journal-title":"N Engl J Med"},{"key":"4691_CR20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.mce.2011.06.014","volume":"350","author":"A McCurley","year":"2012","unstructured":"McCurley A, Jaffe IZ. Mineralocorticoid receptors in vascular function and disease. Mol Cell Endocrinol, 2012, 350: 256\u2013265","journal-title":"Mol Cell Endocrinol"},{"key":"4691_CR21","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.ijcard.2012.05.034","volume":"167","author":"MA Hillaert","year":"2013","unstructured":"Hillaert MA, Lentjes EG, Kemperman H, van der Graaf Y, Nathoe HM, Beygui F, Montalescot G, Doevendans PA, Wassink AM, van Belle E, Group SS. Aldosterone, atherosclerosis and vascular events in patients with stable coronary artery disease. Int J Cardiol, 2013, 167: 1929\u20131935","journal-title":"Int J Cardiol"},{"key":"4691_CR22","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.cjca.2012.04.014","volume":"28","author":"O Rita de","year":"2012","unstructured":"de Rita O, Hackam DG, Spence JD. Effects of aldosterone on human atherosclerosis: plasma aldosterone and progression of carotid plaque. Can J Cardiol, 2012, 28: 706\u2013711","journal-title":"Can J Cardiol"},{"key":"4691_CR23","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol, 2005, 45: 1243\u20131248","journal-title":"J Am Coll Cardiol"},{"key":"4691_CR24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/HYPERTENSIONAHA.107.095885","volume":"51","author":"D Weiss","year":"2008","unstructured":"Weiss D, Taylor WR. Deoxycorticosterone acetate salt hypertension in apolipoprotein E\u2212\/\u2212 mice results in accelerated atherosclerosis: the role of angiotensin II. Hypertension, 2008, 51: 218\u2013224","journal-title":"Hypertension"},{"key":"4691_CR25","doi-asserted-by":"crossref","first-page":"e000018","DOI":"10.1161\/JAHA.112.000018","volume":"2","author":"AP McGraw","year":"2013","unstructured":"McGraw AP, Bagley J, Chen WS, Galayda C, Nickerson H, Armani A, Caprio M, Carmeliet P, Jaffe IZ. Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism. J Am Heart Assoc, 2013, 2: e000018","journal-title":"J Am Heart Assoc"},{"key":"4691_CR26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000345243","volume":"50","author":"M Briet","year":"2012","unstructured":"Briet M, Schiffrin EL. Vascular Actions of Aldosterone. J Vasc Res, 2012, 50: 89\u201399","journal-title":"J Vasc Res"},{"key":"4691_CR27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/hc3001.091458","volume":"104","author":"MR Ward","year":"2001","unstructured":"Ward MR, Kanellakis P, Ramsey D, Funder J, Bobik A. Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries. Circulation, 2001, 104: 467\u2013472","journal-title":"Circulation"},{"key":"4691_CR28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.pcad.2009.12.004","volume":"52","author":"A Whaley-Connell","year":"2010","unstructured":"Whaley-Connell A, Johnson MS, Sowers JR. Aldosterone: role in the cardiometabolic syndrome and resistant hypertension. Prog Cardiovasc Dis, 2010, 52: 401\u2013409","journal-title":"Prog Cardiovasc Dis"},{"key":"4691_CR29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.107.095489","volume":"51","author":"NJ Brown","year":"2008","unstructured":"Brown NJ. Aldosterone and vascular inflammation. Hypertension, 2008, 51: 161\u2013167","journal-title":"Hypertension"},{"key":"4691_CR30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijcard.2005.03.078","volume":"107","author":"K Wakabayashi","year":"2006","unstructured":"Wakabayashi K, Suzuki H, Sato T, Iso Y, Katagiri T, Takeyama Y. Eplerenone suppresses neointimal formation after coronary stent implantation in swine. Int J Cardiol, 2006, 107: 260\u2013266","journal-title":"Int J Cardiol"},{"key":"4691_CR31","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.HYP.0000034738.79310.06","volume":"40","author":"A Virdis","year":"2002","unstructured":"Virdis A, Neves MF, Amiri F, Viel E, Touyz RM, Schiffrin EL. Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension, 2002, 40: 504\u2013510","journal-title":"Hypertension"},{"key":"4691_CR32","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1161\/01.HYP.0000128031.31572.a3","volume":"43","author":"DH Endemann","year":"2004","unstructured":"Endemann DH, Touyz RM, Iglarz M, Savoia C, Schiffrin EL. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats. Hypertension, 2004, 43: 1252\u20131257","journal-title":"Hypertension"},{"key":"4691_CR33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.atherosclerosis.2009.01.039","volume":"206","author":"S Sakurabayashi-Kitade","year":"2009","unstructured":"Sakurabayashi-Kitade S, Aoka Y, Nagashima H, Kasanuki H, Hagiwara N, Kawana M. Aldosterone blockade by Spironolactone improves the hypertensive vascular hypertrophy and remodeling in angiotensin II overproducing transgenic mice. Atherosclerosis, 2009, 206: 54\u201360","journal-title":"Atherosclerosis"},{"key":"4691_CR34","doi-asserted-by":"crossref","first-page":"L678","DOI":"10.1152\/ajplung.00300.2012","volume":"304","author":"IR Preston","year":"2013","unstructured":"Preston IR, Sagliani KD, Warburton RR, Hill NS, Fanburg BL, Jaffe IZ. Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol, 2013, 304): L678\u2013688","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4691_CR35","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/00005344-200306000-00019","volume":"41","author":"S Keidar","year":"2003","unstructured":"Keidar S, Hayek T, Kaplan M, Pavlotzky E, Hamoud S, Coleman R, Aviram M. Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice. J Cardiovasc Pharmacol, 2003, 41: 955\u2013963","journal-title":"J Cardiovasc Pharmacol"},{"key":"4691_CR36","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000015854.60710.10","volume":"105","author":"S Rajagopalan","year":"2002","unstructured":"Rajagopalan S, Duquaine D, King S, Pitt B, Patel P. Mineralocorticoid receptor antagonism in experimental atherosclerosis. Circulation, 2002, 105: 2212\u20132216","journal-title":"Circulation"},{"key":"4691_CR37","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/01.HYP.0000184640.81730.22","volume":"46","author":"S Takai","year":"2005","unstructured":"Takai S, Jin D, Muramatsu M, Kirimura K, Sakonjo H, Miyazaki M. Eplerenone inhibits atherosclerosis in nonhuman primates. Hypertension, 2005, 46: 1135\u20131139","journal-title":"Hypertension"},{"key":"4691_CR38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2014.01.043","volume":"726C","author":"K Labuzek","year":"2014","unstructured":"Labuzek K, Liber S, Buldak L, Krupej-Kedzierska J, Machnik G, Bobrzyk M, Okopien B. Eplerenone mimics features of the alternative activation in macrophages obtained from patients with heart failure and healthy volunteers. Eur J Pharmacol, 2014, 726C: 96\u2013108","journal-title":"Eur J Pharmacol"},{"key":"4691_CR39","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1734-1140(13)70983-6","volume":"65","author":"K Labuzek","year":"2013","unstructured":"Labuzek K, Liber S, Buldak L, Machnik G, Liber J, Okopien B. Eplerenone promotes alternative activation in human monocytederived macrophages. Pharmacol Rep, 2013, 65: 226\u2013234","journal-title":"Pharmacol Rep"},{"key":"4691_CR40","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/nm.2891","volume":"18","author":"A McCurley","year":"2012","unstructured":"McCurley A, Pires PW, Bender SB, Aronovitz M, Zhao MJ, Metzger D, Chambon P, Hill MA, Dorrance AM, Mendelsohn ME, Jaffe IZ. Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nat Med, 2012, 18: 1429\u20131433","journal-title":"Nat Med"},{"key":"4691_CR41","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/ATVBAHA.113.302854","volume":"34","author":"D Pruthi","year":"2014","unstructured":"Pruthi D, McCurley A, Aronovitz M, Galayda C, Karumanchi SA, Jaffe IZ. Aldosterone promotes vascular remodeling by direct effects on smooth muscle cell mineralocorticoid receptors. Arterioscler Thromb Vasc Biol, 2014, 34: 355\u2013364","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4691_CR42","first-page":"834","volume":"76","author":"Y Rautureau","year":"2011","unstructured":"Rautureau Y, Paradis P, Schiffrin EL. Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells. Steroids, 2011, 76: 834\u2013839","journal-title":"Steroids"},{"key":"4691_CR43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.mce.2011.07.045","volume":"350","author":"C Grossmann","year":"2012","unstructured":"Grossmann C, Gekle M. Interaction between mineralocorticoid receptor and epidermal growth factor receptor signaling. Mol Cell Endocrinol, 2012, 350: 235\u2013241","journal-title":"Mol Cell Endocrinol"},{"key":"4691_CR44","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1096\/fj.09-147926","volume":"24","author":"A Nguyen Dinh Cat","year":"2010","unstructured":"Nguyen Dinh Cat A, Griol-Charhbili V, Loufrani L, Labat C, Benjamin L, Farman N, Lacolley P, Henrion D, Jaisser F. The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure. FASEB J, 2010, 24: 2454\u20132463","journal-title":"FASEB J"},{"key":"4691_CR45","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1093\/eurheartj\/eht095","volume":"34","author":"N Schafer","year":"2013","unstructured":"Schafer N, Lohmann C, Winnik S, van Tits LJ, Miranda MX, Vergopoulos A, Ruschitzka F, Nussberger J, Berger S, Luscher TF, Verrey F, Matter CM. Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity. Eur Heart J, 2013, 34: 3515\u20133524","journal-title":"Eur Heart J"},{"key":"4691_CR46","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1161\/HYPERTENSIONAHA.113.01803","volume":"63","author":"AJ Rickard","year":"2014","unstructured":"Rickard AJ, Morgan J, Chrissobolis S, Miller AA, Sobey CG, Young MJ. Endothelial cell mineralocorticoid receptors regulate deoxycorticosterone\/salt-mediated cardiac remodeling and vascular reactivity but not blood pressure. Hypertension, 2014, 63: 1033\u20131040","journal-title":"Hypertension"},{"key":"4691_CR47","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/CIRCRESAHA.108.174235","volume":"102","author":"M Caprio","year":"2008","unstructured":"Caprio M, Newfell BG, la Sala A, Baur W, Fabbri A, Rosano G, Mendelsohn ME, Jaffe IZ. Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion. Circ Res, 2008, 102: 1359\u20131367","journal-title":"Circ Res"},{"key":"4691_CR48","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1210\/en.2010-0925","volume":"152","author":"GA Deuchar","year":"2011","unstructured":"Deuchar GA, McLean D, Hadoke PW, Brownstein DG, Webb DJ, Mullins JJ, Chapman K, Seckl JR, Kotelevtsev YV. 11beta-hydroxysteroid dehydrogenase type 2 deficiency accelerates atherogenesis and causes proinflammatory changes in the endothelium in ApoE\u2212\/\u2212 mice. Endocrinology, 2011, 152: 236\u2013246","journal-title":"Endocrinology"},{"key":"4691_CR49","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1210\/en.2007-0864","volume":"149","author":"F Iwashima","year":"2008","unstructured":"Iwashima F, Yoshimoto T, Minami I, Sakurada M, Hirono Y, Hirata Y. Aldosterone induces superoxide generation via Rac1 activation in endothelial cells. Endocrinology, 2008, 149: 1009\u20131014","journal-title":"Endocrinology"},{"key":"4691_CR50","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm1545","volume":"13","author":"JA Leopold","year":"2007","unstructured":"Leopold JA, Dam A, Maron BA, Scribner AW, Liao R, Handy DE, Stanton RC, Pitt B, Loscalzo J. Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat Med, 2007, 13: 189\u2013197","journal-title":"Nat Med"},{"key":"4691_CR51","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1161\/01.CIR.0000093188.53554.44","volume":"108","author":"SL Liu","year":"2003","unstructured":"Liu SL, Schmuck S, Chorazcyzewski JZ, Gros R, Feldman RD. Aldosterone regulates vascular reactivity: short-term effects mediated by phosphatidylinositol 3-kinase-dependent nitric oxide synthase activation. Circulation, 2003, 108: 2400\u20132406","journal-title":"Circulation"},{"key":"4691_CR52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/01.HYP.0000226054.53527.bb","volume":"48","author":"D Nagata","year":"2006","unstructured":"Nagata D, Takahashi M, Sawai K, Tagami T, Usui T, Shimatsu A, Hirata Y, Naruse M. Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity. Hypertension, 2006, 48: 165\u2013171","journal-title":"Hypertension"},{"key":"4691_CR53","volume-title":"Steroids","author":"NC Bene","year":"2014","unstructured":"Bene NC, Alcaide P, Wortis HH, Jaffe IZ. Mineralocorticoid receptors in immune cells: emerging role in cardiovascular disease. Steroids, 2014, doi: 10.1016\/j.steroids.2014.04.005"},{"key":"4691_CR54","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4049\/jimmunol.0802886","volume":"184","author":"AA Herrada","year":"2010","unstructured":"Herrada AA, Contreras FJ, Marini NP, Amador CA, Gonzalez PA, Cortes CM, Riedel CA, Carvajal CA, Figueroa F, Michea LF, Fardella CE, Kalergis AM. Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity. J Immunol, 2010, 184: 191\u2013202","journal-title":"J Immunol"},{"key":"4691_CR55","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/eji.201344265","volume":"44","author":"L Besedovsky","year":"2014","unstructured":"Besedovsky L, Linz B, Born J, Lange T. Mineralocorticoid receptor signaling reduces numbers of circulating human naive T cells and increases their CD62L, CCR7, and CXCR4 expression. Eur J Immunol, 2014, 44: 1759\u20131769","journal-title":"Eur J Immunol"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-014-4691-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11427-014-4691-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-014-4691-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T14:05:31Z","timestamp":1498140331000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11427-014-4691-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["4691"],"URL":"https:\/\/doi.org\/10.1007\/s11427-014-4691-5","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}